Abstract: Biological tissues may be prepared for use in biological prostheses. The biological tissue may be fixated with glutaraldehyde and may be subjected to successive treatment of the tissue with a solution containing taurine to neutralize excess aldehyde groups that remain free after fixation.

Abstract: Biological tissues may be prepared for use in biological prostheses. The biological tissue may be fixated with glutaraldehyde and may be subjected to successive treatment of the tissue with a solution containing taurine to neutralize excess aldehyde groups that remain free after fixation.

Abstract: Biological tissues may be prepared for use in biological prostheses. The biological tissue may be fixated with glutaraldehyde and may be subjected to successive treatment of the tissue with a solution containing taurine to neutralize excess aldehyde groups that remain free after fixation.

Abstract: A process for depositing an active substance on selected regions of the surface of a stent, comprising: (i) providing the active substance in at least one form selected from the group consisting of a powder and a paste; and (ii) depositing the active substance on the selected regions of the surface of the stent. Preferably, the active substance comprises or consists essentially of FK506, such as FK506 in the form of a powder with a grain size smaller than 15 micron or a paste with a base of FK506 with a viscosity not lower than 100,000 to 120,000 cps.

Abstract: Biological tissues may be prepared for use in biological prostheses. The biological tissue may be fixated with glutaraldehyde and may be subjected to successive treatment of the tissue with a solution containing taurine to neutralize excess aldehyde groups that remain free after fixation.

Abstract: A process for depositing an active substance on selected regions of the surface of a stent, comprising: (i) providing the active substance in at least one form selected from the group consisting of a powder and a paste; and (ii) depositing the active substance on the selected regions of the surface of the stent. Preferably, the active substance comprises or consists essentially of FK506, such as FK506 in the form of a powder with a grain size smaller than 15 micron or a paste with a base of FK506 with a viscosity not lower than 100,000 to 120,000 cps.

Abstract: A process for setting an angioplasty stent on a corresponding insertion element, such as a delivery catheter, in which the angioplasty stent is subjected to an action of radial contraction. The stent is in a radially contracted state before being placed on the insertion element. Preferably, radial contraction of the stent results in a diameter at least marginally smaller than the diameter of the insertion element, e.g., a balloon catheter. After the stent has been set on the insertion element, in the structure of the stent there remain residual states of constraint which act in the direction of securing the stent in the condition of coupling to the insertion element.

Abstract: A process for depositing an active substance on selected regions of the surface of a stent, comprising: (i) providing the active substance in at least one form selected from the group consisting of a powder and a paste; and (ii) depositing the active substance on the selected regions of the surface of the stent.

Abstract: A process for setting an angioplasty stent on a corresponding insertion element, such as a delivery catheter, in which the angioplasty stent is subjected to an action of radial contraction. The stent is in a radially contracted state before being placed on the insertion element. Preferably, radial contraction of the stent results in a diameter at least marginally smaller than the diameter of the insertion element, e.g., a balloon catheter. After the stent has been set on the insertion element, in the structure of the stent there remain residual states of constraint which act in the direction of securing the stent in the condition of coupling to the insertion element.